# Junta clínica — PT-pseudo_f99f0627e536 (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_f99f0627e536",
  "pid": "PT-pseudo_f99f0627e536",
  "task": 1,
  "psa": 10.0,
  "age": 70,
  "months": 2,
  "pirads": "5",
  "psad": 0.349,
  "psav": 2.0,
  "psap": 5.6,
  "vol": 28.64,
  "dre": "Normal",
  "bx": "Positive",
  "cspca": 0.83261764,
  "medhx": "Not reported",
  "meds": "None",
  "notes": "PSA 10 ng/mL. PI-RADS 5. PSAD 0.35. Prostate volume 29 mL. csPCa 0.83.",
  "pmhx": [],
  "allergies": [],
  "vitals": {
    "weight": "112 kg",
    "height": "181 cm",
    "bmi": "34.2",
    "bp": "104/81 mmHg",
    "hr": "82 bpm",
    "smoking": "Non-smoker",
    "last_dental": "2 yr ago",
    "flu_vax": "Nov 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "13 Jan 2025",
  "enc_ref": "Dr. R. van den Berg (GP)",
  "enc_type": "Re-evaluation - prior PCa diagnosis",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Post-prostatectomy monitoring revealed a PSA increase to 10.0 ng/mL, necessitating immediate specialist review."
    },
    {
      "s": "History",
      "t": "At age seventy, the patient works as a retired greenhouse horticulturalist and resides with his wife. After an initial PSA elevation in 2022 prompted a radical prostatectomy when he was sixty-nine, he has maintained strict surveillance protocols. His current PSA stands at 10.0 ng/mL. He reports no urinary blockage, blood in the urine, or skeletal discomfort, recording a minimal IPSS of 1 out of 35. Alcohol consumption averages twenty-six units per week, and he regularly hikes on weekends. Beyond urological matters, he completed a six-session physiotherapy regimen for persistent lower back strain and underwent baseline cognitive screening at a memory clinic; both interventions are progressing without complication. He smokes nothing and requires no daily pharmacotherapy."
    },
    {
      "s": "Physical examination",
      "t": "DRE — texture: smooth; mobility: unrestricted; asymmetry: absent. The prostatic fossa presents symmetrically without palpable irregularities. Vital signs remain stable, and systemic examination shows no acute abnormalities. While a walking frame assists him during extended ambulation, his baseline functional capacity remains solid for routine tasks."
    }
  ],
  "occupation": "retired greenhouse horticulturalist",
  "marital": "Married",
  "living": "Lives with partner",
  "next_of_kin": "Sibling (brother)",
  "recent_other": [
    "Memory clinic — baseline screening",
    "Physiotherapy — lower back, six sessions"
  ],
  "alcohol": "26 units / week",
  "exercise": "Hiking on weekends",
  "ipss": "IPSS score: 1/35 (mild LUTS)",
  "admin": "Mobility limitation (frame); ground-floor consult room preferred.",
  "mri_hospital": "Erasmus MC",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_f99f0627e536
Task: 1

Encounter: Urology - outpatient on 13 Jan 2025.
Referrer: Dr. R. van den Berg (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 70-year-old male
  - PSA: 10.0 ng/mL
  - mpMRI — PI-RADS score: 5 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.349 ng/mL²
  - PSA velocity: 2.0 ng/mL/yr
  - Prior PSA: 5.6 ng/mL
  - Prostate volume: 28.64 mL
  - Months since last PSA: 2
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.83261764 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Not reported
  - Problem list / PMHx: none recorded
  - Current medication: None
  - Allergies: NKA
  - Additional notes: PSA 10 ng/mL. PI-RADS 5. PSAD 0.35. Prostate volume 29 mL. csPCa 0.83.

Vitals: weight 112 kg, height 181 cm, BMI 34.2, BP 104/81 mmHg, HR 82 bpm. Smoking: Non-smoker.

Chief complaint: Post-prostatectomy monitoring revealed a PSA increase to 10.0 ng/mL, necessitating immediate specialist review.

History: At age seventy, the patient works as a retired greenhouse horticulturalist and resides with his wife. After an initial PSA elevation in 2022 prompted a radical prostatectomy when he was sixty-nine, he has maintained strict surveillance protocols. His current PSA stands at 10.0 ng/mL. He reports no urinary blockage, blood in the urine, or skeletal discomfort, recording a minimal IPSS of 1 out of 35. Alcohol consumption averages twenty-six units per week, and he regularly hikes on weekends. Beyond urological matters, he completed a six-session physiotherapy regimen for persistent lower back strain and underwent baseline cognitive screening at a memory clinic; both interventions are progressing without complication. He smokes nothing and requires no daily pharmacotherapy.

Physical examination: DRE — texture: smooth; mobility: unrestricted; asymmetry: absent. The prostatic fossa presents symmetrically without palpable irregularities. Vital signs remain stable, and systemic examination shows no acute abnormalities. While a walking frame assists him during extended ambulation, his baseline functional capacity remains solid for routine tasks.

Patient info: retired greenhouse horticulturalist; Married; Lives with partner.
Next of kin: Sibling (brother).

Lifestyle: alcohol 26 units / week; exercise Hiking on weekends; IPSS score: 1/35 (mild LUTS).

Recent other appointments: Memory clinic — baseline screening; Physiotherapy — lower back, six sessions.
Admin: Mobility limitation (frame); ground-floor consult room preferred.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: BIOPSY   p(biopsy) = 0.63
  uncertainty  +/- 0.09 epistemic (95% band 0.46-0.80); among patients I cannot tell apart the outcome was 0.95 of 1.00 mixed
  reliability  MODERATE ('supports' tier) — out-of-fold it was right 60% of the time over the 20 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; the levels are what moved my prediction across the series, not what a urologist would mark)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  comorbidity = none recorded (21% of my signal; from pmhx_hypercholesterolaemia, n_comorbidities)
  noted      age = 70 (2% of my signal; from age) · DRE = Normal (10% of my signal; from dre_suspicious) · PSA = 10 ng/mL (3% of my signal; from log_psa, psav) · prostate volume = 28.64 mL (1% of my signal; from log_vol, vol) · PSA density = 0.349 (0% of my signal; from psad_calc, log_psad) · csPCa probability = 0.83 (1% of my signal; from cspca) · PI-RADS = 5 (20% of my signal; from pirads_ge4, pirads_ge3)
  not used   family history
CONFIDENCE: borderline — 'supports' tier; out-of-fold it was right 60% of the time over the 20 labelled cases in this tier

I read 39 raw variables, all from the panel — nothing from the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory. Out-of-fold over 91 labelled cases: AUC
0.758, balanced accuracy 0.625.
The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: prior positive biopsy. The panel alone does not answer, and that is the finding.

The criterion here is that the visible panel does not determine this decision: he already has a tissue diagnosis, so neither a high PI-RADS nor a rising PSA is new information. What decides it is the documented grade of the prior biopsy and the surveillance history, which live in the previous notes. Measured on the labelled series: none of the three panel
rules I carry for this situation (PSA >= 20, age >= 78, PI-RADS <= 2) applies to him, and among the
39 remaining labelled men in this situation no structured variable separates the two answers.

REGISTRAR: the previous notes are where this case is decided. Read them for the grade of the prior
biopsy (Gleason or ISUP), the number of biopsy sessions and their dates, and whether he is on a
surveillance protocol with a confirmatory biopsy due. Do not read this as 'defer' and do not read it
as 'biopsy'.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; 'decisive' marks the variable the rule turns on)
  important  prior biopsy = Positive
  noted      age = 70 · DRE = Normal · PSA = 10 ng/mL · prostate volume = 28.64 mL · PSA density = 0.349 · PI-RADS = 5 · comorbidity = none recorded
  not used   family history, csPCa probability
CONFIDENCE: uncertain — none of my three panel rules applies; the fact that would settle it — the documented prior grade — lives in the notes, not on the panel

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 49 labelled men in this same situation (Positive prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 0.66: PI-RADS 5, PSA 9.3, PSAD 0.516, age 71, DRE Normal -> DEFER (clear). He wrote: "He has a ISUP3 cancer diagnosis already and he should be recommended treatment"
  2. distance 0.72: PI-RADS 5, PSA 10.0, PSAD 0.372, age 75, DRE Normal -> BIOPSY (clear). He wrote: "Intermediate risk disease in 75yr with some comorbidity. No targeted biopsy and unclear timing (when was diagnosis and prev biopsy). Unclear if PIRADS5 was biopsied (lim…"
  3. distance 0.74: PI-RADS 5, PSA 13.5, PSAD 0.452, age 66, DRE Normal -> BIOPSY (clear). He wrote: "PIRADS 5 lesion in a man in active surveillance."

PRECEDENT: BIOPSY (weighted vote 0.64 for biopsy). Distance-weighted precedent is no better than chance here (0.47 leave-one-out): read the precedents for how this urologist reasons, not for the answer.

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

WHAT THE READING UROLOGIST WEIGHED IN THESE PRECEDENTS — in the form's vocabulary, with this man's values (weighted majority of the 3 nearest labelled traces; the distance itself is on PI-RADS, prior biopsy first)
  important  prior biopsy = Positive · age = 70 · PI-RADS = 5
  noted      DRE = Normal · PSA = 10 ng/mL · prostate volume = 28.64 mL · PSA density = 0.349 · comorbidity = none recorded
  not used   family history, csPCa probability
CONFIDENCE: uncertain — in this situation the library is no better than chance (47% out of fold)

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 49 labelled traces in this situation (Positive prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes, laboratory_results.

WHAT HE WEIGHS — in the form's vocabulary, with this man's values (these are the levels that go on the form, unless a colleague shows a reason to move one)
  decisive   PI-RADS = 5
  important  prior biopsy = Positive · age = 70 · PSA = 10 ng/mL
  noted      family history = not opened (0 of 91) · DRE = Normal · prostate volume = 28.64 mL · PSA density = 0.349 · comorbidity = none recorded
  not used   csPCa probability
CONFIDENCE: clear — the level the reading urologist records in this situation, from his labelled traces

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
"linking PI-RADS score (1-2, 3, and 4-5) to PSA-D categories (< 0.10, 0.10-0.15, 0.15-0.20 and > 0.20ng/mL) (Table 5.5) [230]. This risk-adapted matrix table may guide the decision to perform a biopsy."
The guideline suggests using a risk-adapted matrix table based on PI-RADS score and PSA density to guide the decision to perform a biopsy. This patient's PI-RADS score is 5 and PSA density is 0.349 ng/mL², which falls into the highest risk category according to the retrieved data.

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, your bid of BIOPSY p(biopsy) = 0.63 is high, but the guideline treats the PI-RADS score and PSA density as key determinants. The guideline suggests that for high-risk profiles, a biopsy may be indicated based on the risk matrix. The guideline makes the PI-RADS score and PSA density decisive, whereas EXPERT-STRUCTURED marked PI-RADS as decisive and EXPERT-FUSION only important. The guideline requires the PI-RADS score and PSA density to be used in the risk matrix. The guideline needs the prior grade of the prior biopsy to be established to determine the subsequent pathway.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the prior biopsy status: at Positive the guideline suggests the decision depends on the prior grade and surveillance history.
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does
psa_trend - the PSA trend: the guideline suggests the PSA trend is a factor in the risk matrix.
laboratory_results - the laboratory results: the guideline suggests the PSA density is a factor in the risk matrix.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

This case hinges on establishing the prior grade of the biopsy and the surveillance history documented in the previous notes, as the current panel alone is insufficient.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Does the mpMRI prose indicate whether the lesion is compared against an earlier study?
  psa_trend (get_psa_trend) -> What is the PSA trend (rising, flat, or falling)?
  previous_notes (get_previous_notes) -> What is the GRADE (Gleason or ISUP) of the prior biopsy, the number and dates of biopsy sessions, and whether he is on a surveillance protocol with a confirmatory biopsy due?
  laboratory_results (get_lab_results) -> What is the PSA density value as used in the risk matrix?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the GRADE (Gleason or ISUP) of the prior biopsy?
  Q2. Is the patient on a SURVEILLANCE protocol with a confirmatory biopsy due?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
Subject: Multiparametric MRI of the Prostate | 10 January 2025 | Radiology Department
COMPARISON: new
LESION: PI-RADS 5 lesion in the left mid-gland prostatic remnant.

psa_trend
PSA trend: rising, from 2.0 (Jan 2022) to 10.0 (Jan 2025).

previous_notes
PRIOR GRADE: not recorded
BIOPSY SESSIONS: not recorded
SURVEILLANCE: not recorded
TREATMENT: none recorded

laboratory_results
PSA 10.0 ng/mL (Dec 25 Dec 2024), Free PSA 1.28 ng/mL (Dec 25 Dec 2024), %Free PSA 13% (Dec 25 Dec 2024).

WHAT I DID NOT OPEN
family-history anamnesis, as it was not requested by the moderator.

WHAT THIS SUPPORTS
FOR sampling this patient now
PI-RADS 5 lesion in the left mid-gland prostatic remnant (radiology_report)
PSA trend is rising, from 2.0 (Jan 2022) to 10.0 (Jan 2025) (psa_trend)

AGAINST sampling this patient now
prior biopsy status is not recorded (previous_notes)

WHERE THIS LEANS
LEAN: biopsy

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 10.00 ng/mL over 3 points spanning 36 months; velocity +2.67 ng/mL per year; doubling time about 16 months.
PROJECTION at 6 months: 16.6 ng/mL, conformal 95% band 4.8-57.9.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (the serial PSA only)
  noted      PSA = 10 ng/mL
  not used   prior biopsy, family history, age, DRE, prostate volume, PSA density, csPCa probability, PI-RADS, comorbidity
CONFIDENCE: borderline — the conformal band does not clear the last value

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report and the laboratory panel; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.59
  uncertainty  +/- 0.08 epistemic (95% band 0.42-0.75), of which 0.00 comes from values that had to be imputed
  reliability  MODERATE ('supports' tier) — out-of-fold it was right 71% of the time over the 24 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel + the documents that were opened; PI-RADS here means the report's own wording — DWI restriction, lesion size — not the score)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  PI-RADS = 5 (22% of my signal; from rad_dwi_restriction, rad_lesion_ge15mm)
  noted      DRE = Normal (5% of my signal; from dre_suspicious) · PSA = 10 ng/mL (21% of my signal; from fpsa_lt15, psa_delta_prev) · prostate volume = 28.64 mL (4% of my signal; from log_vol, vol) · PSA density = 0.349 (0% of my signal; from psad_calc) · comorbidity = none recorded (4% of my signal; from n_comorbidities, on_alpha_blocker)
  not used   family history, age, csPCa probability
CONFIDENCE: borderline — 'supports' tier; out-of-fold it was right 71% of the time over the 24 labelled cases in this tier

Out-of-fold AUC 0.794. I am the only expert that has read the report's
wording, and I still cannot see the prior grade or the surveillance history: those are in the notes, and
the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  BIOPSY, p(biopsy)=0.63  ('supports' tier; weight 2.0)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.59  ('supports' tier, fusion_full; weight 3.0)
  EXPERT-LIBRARY     BIOPSY, p(biopsy)=0.64  (k=3 precedents; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: weighted vote of the trained experts, p = 0.60 — carried by weighted panel.
PANEL ANSWER: BIOPSY. EXPERT-FUSION carried the most weight ('supports' tier, fusion_full). In this bucket no rule applied and the documents did not record the prior grade, so the trained experts decide.

THE BOARD'S VARIABLES — value · what each expert marked · what goes on the form
  bx           Positive                     E1:DEC E3:DEC cohort:IMP library:IMP E2:—            -> important
  fh           not opened (0 of 91)         E1:— E3:— cohort:— library:— E2:—                    -> not_used (raised from noted by the board)
  age          70                           E1:not E3:— cohort:not library:IMP E2:—              -> important
  dre          Normal                       E1:not E3:not cohort:not library:not E2:—            -> noted
  psa          10 ng/mL                     E1:not E3:not cohort:not library:not E2:not          -> important
  vol          28.64 mL                     E1:not E3:not cohort:not library:not E2:—            -> noted
  psad         0.349                        E1:not E3:not cohort:not library:not E2:—            -> noted
  cspca        0.83                         E1:not E3:— cohort:— library:— E2:—                  -> not_used
  pirads       5                            E1:not E3:IMP cohort:not library:IMP E2:—            -> decisive
  comorbidity  none recorded                E1:IMP E3:not cohort:not library:not E2:—            -> noted
  (DEC decisive · IMP important · not noted · — not used; the last column is the level recorded, from the trace of the reading urologist)

Confidence to record: clear.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents the registrar opened (radiology_report, psa_trend, previous_notes, laboratory_results) address the moderator's questions by providing information on the PSA trend and the PI-RADS 5 lesion, but they do not explicitly state the GRADE of the prior biopsy or whether the patient is on a surveillance protocol with a confirmatory biopsy due.

ALIGNMENT WITH THE PANEL
The retrieved evidence does not directly confirm or refute the PANEL-PROTOCOL's answer of BIOPSY, as the critical variables Q1 (prior grade) and Q2 (surveillance status) remain unaddressed by the retrieved data.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the GRADE (Gleason or ISUP) of the prior biopsy? Not answered by any intervention.
Q2. Is the patient on a SURVEILLANCE protocol with a confirmatory biopsy due? Not answered by any intervention.

WHAT CARRIES WEIGHT, AND WHY
<prior biopsy>: Positive (noted) because the EXPERT-STRUCTURED and EXPERT-FUSION both marked this as decisive, and the EXPERT-LIBRARY precedent was positive. I would move this to 'decisive' if the prior grade were known, as it is the key variable the PANEL-PROTOCOL explicitly states is missing.
<psa>: 10 ng/mL (important) because it was noted by multiple experts, and the EXPERT-PSA showed a rising trajectory, which is a factor in the EAU guideline. I would keep this as important.
<comorbidity>: none recorded (important) because EXPERT-STRUCTURED marked this as important, and the EAU guideline suggests risk stratification based on multiple factors. I would keep this as important.
My confidence in the record as it stands is borderline because the core variables required by the guideline (prior grade and surveillance status) are missing.

MY SUGGESTION TO THE CHAIR
The record is not in a state to be decided because the critical information required by the EAU guideline—the prior biopsy grade and surveillance status—is not present in the retrieved documents.

VERDICT: not-ready | SUGGEST: defer | MISSING: previous_notes

[The conference closes after pass 1: every document on the plan is open; nothing outside the plan is ever opened. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: clear)

70y male, PSA 10.0, PSAD 0.349, PI-RADS 5, prior biopsy grade not recorded. High PI-RADS 5 and rising PSA suggest need for tissue diagnosis. Lack of prior grade mandates biopsy to determine management pathway.

What carried weight: bx=important, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=decisive, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes, laboratory_results
